116 related articles for article (PubMed ID: 8014346)
1. Causes of death associated with Alzheimer disease: variation by level of cognitive impairment before death.
Kukull WA; Brenner DE; Speck CE; Nochlin D; Bowen J; McCormick W; Teri L; Pfanschmidt ML; Larson EB
J Am Geriatr Soc; 1994 Jul; 42(7):723-6. PubMed ID: 8014346
[TBL] [Abstract][Full Text] [Related]
2. Causes of Death According to Death Certificates in Individuals with Dementia: A Cohort from the Swedish Dementia Registry.
Garcia-Ptacek S; Kåreholt I; Cermakova P; Rizzuto D; Religa D; Eriksdotter M
J Am Geriatr Soc; 2016 Nov; 64(11):e137-e142. PubMed ID: 27801938
[TBL] [Abstract][Full Text] [Related]
3. Mortality in elderly Canadians with and without dementia: a 5-year follow-up.
Ostbye T; Hill G; Steenhuis R
Neurology; 1999 Aug; 53(3):521-6. PubMed ID: 10449114
[TBL] [Abstract][Full Text] [Related]
4. Cause of death in Alzheimer's disease: a cohort study.
Todd S; Barr S; Passmore AP
QJM; 2013 Aug; 106(8):747-53. PubMed ID: 23653484
[TBL] [Abstract][Full Text] [Related]
5. [Causes of death in hospitalized elderly patients].
Nakajima N; Aiba M; Fukuda Y; Boku S; Isonuma H; Tsuda H; Hayashida Y
Nihon Ronen Igakkai Zasshi; 2009 Jan; 46(1):71-8. PubMed ID: 19246838
[TBL] [Abstract][Full Text] [Related]
6. Death certification in treated cases of presenile Alzheimer's disease and vascular dementia in Scotland.
Thomas BM; Starr JM; Whalley LJ
Age Ageing; 1997 Sep; 26(5):401-6. PubMed ID: 9351485
[TBL] [Abstract][Full Text] [Related]
7. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
8. Neuropathology of older persons without cognitive impairment from two community-based studies.
Bennett DA; Schneider JA; Arvanitakis Z; Kelly JF; Aggarwal NT; Shah RC; Wilson RS
Neurology; 2006 Jun; 66(12):1837-44. PubMed ID: 16801647
[TBL] [Abstract][Full Text] [Related]
9. Reporting of dementia on death certificates: a community study.
Ganguli M; Rodriguez EG
J Am Geriatr Soc; 1999 Jul; 47(7):842-9. PubMed ID: 10404929
[TBL] [Abstract][Full Text] [Related]
10. Vascular dementia: a clinical and death certificate study.
Dollear W; Gorelick PB; Harris Y; Miles T; Bozzola F
Neuroepidemiology; 1992; 11(2):53-8. PubMed ID: 1495574
[TBL] [Abstract][Full Text] [Related]
11. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study.
Riekse RG; Leverenz JB; McCormick W; Bowen JD; Teri L; Nochlin D; Simpson K; Eugenio C; Larson EB; Tsuang D
J Am Geriatr Soc; 2004 Sep; 52(9):1442-8. PubMed ID: 15341544
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.
Tarawneh R; D'Angelo G; Crimmins D; Herries E; Griest T; Fagan AM; Zipfel GJ; Ladenson JH; Morris JC; Holtzman DM
JAMA Neurol; 2016 May; 73(5):561-71. PubMed ID: 27018940
[TBL] [Abstract][Full Text] [Related]
13. Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes.
Ascher-Svanum H; Chen YF; Hake A; Kahle-Wrobleski K; Schuster D; Kendall D; Heine RJ
Clin Ther; 2015 Jun; 37(6):1195-205. PubMed ID: 25676448
[TBL] [Abstract][Full Text] [Related]
14. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
[TBL] [Abstract][Full Text] [Related]
15. Symptom patterns and comorbidity in the early stages of Alzheimer's disease.
McCormick WC; Kukull WA; van Belle G; Bowen JD; Teri L; Larson EB
J Am Geriatr Soc; 1994 May; 42(5):517-21. PubMed ID: 8176147
[TBL] [Abstract][Full Text] [Related]
16. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
[TBL] [Abstract][Full Text] [Related]
17. Psychopathological features in Alzheimer's disease: course and relationship with cognitive status.
Holtzer R; Tang MX; Devanand DP; Albert SM; Wegesin DJ; Marder K; Bell K; Albert M; Brandt J; Stern Y
J Am Geriatr Soc; 2003 Jul; 51(7):953-60. PubMed ID: 12834515
[TBL] [Abstract][Full Text] [Related]
18. EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease.
Lopez OL; Brenner RP; Becker JT; Ulrich RF; Boller F; DeKosky ST
Neurology; 1997 Jun; 48(6):1521-5. PubMed ID: 9191759
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer disease with psychosis: excess cognitive impairment is restricted to the misidentification subtype.
Perez-Madriñan G; Cook SE; Saxton JA; Miyahara S; Lopez OL; Kaufer DI; Aizenstein HJ; DeKosky ST; Sweet RA
Am J Geriatr Psychiatry; 2004; 12(5):449-56. PubMed ID: 15353383
[TBL] [Abstract][Full Text] [Related]
20. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
